Hyaluronic Acid-Coated MTX-PEI Nanoparticles for Targeted Rheumatoid Arthritis Therapy
Methotrexate (MTX) is an anchor drug for the treatment of rheumatoid arthritis (RA); however, long-term and high-dose usage of MTX for patients can cause many side effects and toxic reactions. To address these difficulties, selectively delivering MTX to the inflammatory site of a joint is promising...
Main Authors: | Shenghui Zhong, Peng Liu, Jinsong Ding, Wenhu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Crystals |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4352/11/4/321 |
Similar Items
-
The Effects of Cerium Oxide Nanoparticles on the Rat Model of Rheumatoid Arthritis
by: E Naji Zavareh, et al.
Published: (2019-11-01) -
PENTOXIFILLIN INTHETREATMENTOF RHEUMATOID ARTHRITIS
by: I R Kolosova, et al.
Published: (2001-10-01) -
International Survey to Evaluate Current Options for Subcutaneous Injection of Methotrexate (MTX) and a New Button-Free MTX Autoinjector
by: Müller-Ladner U, et al.
Published: (2024-03-01) -
Patterns of Cytopenias Associated with Methotrexate Treated Rheumatoid Arthritis Patients
by: Mohsin Shakoor Malik, et al.
Published: (2023-04-01) -
Methotrexate intolerance in Rheumatoid Arthritis
by: Harjit Singh Nalwa, et al.
Published: (2023-03-01)